Healthcare

Biotechnology Reagents and Kits Market Size, Share, CAGR, Revenue Estimation, Regional Scope and Forecast 2021 to 2030

Share This Article

The global biotechnology reagents & kits market size is projected to hit USD 987.4 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 11.4% from 2021 to 2030.

Growth Factors

Various factors such as increased research activities related to stem cell, growing number of biotechnology companies, and rising investments by the biotechnology firms are the significantly driving the growth of the global biotechnology reagents & kits market. The Government of Australia launched a mission in 2019 and announced to invest around US$ 150 million during the period of 9 years, to support the research activities related to stem cell in order to develop medicines for the incurable diseases. The stem cell research results in the extensive consumption of biotechnology reagents.

Get the sample pages of report@ https://www.precedenceresearch.com/sample/1378

Report Highlights

  • North America dominated the global biotechnology reagents & kits market, garnering around 40% of the market share in 2020. The various developmental activities such as partnerships, acquisitions, and new product launches undertaken by the local key players, significantly influences the market growth in the region. Further, rising government and corporate investments in the development of various medicines and vaccines is boosting the growth of the biotechnology industry in North America, which led to the biotechnology reagents & kits market growth.
  • Asia Pacific is estimated to be the most opportunistic market during the forecast period. The rapidly growing biotechnology industry in the Asia Pacific, rising demand for the innovative therapeutics, and growing penetration of numerous biotechnology companies in the region is propelling the growth of the biotechnology reagents & kits market in the region.
  • Based on the technology, the cell culture dominated the market, closely followed by the PCR segment. The cell culture accounted for around 25% of the market share in 2020. The growing demand for the cell culture reagents among the researchers is the major factor behind the segment’s growth.
  • Based on the kits type, the detection segment dominated the market, accounting for around 23% of the market share in 2020. The surged use of detection kits in various end use applications such as healthcare, agriculture, and industrial processing has significantly fostered the market growth
  • Based on the micro-organisms, the bacteria is estimated to be the most opportunistic segment due to its increasing adoption in the cancer treatment. According to the International Agency for Research on Cancer, around 19.3 million new cancer cases and around 10 million cancer related deaths were reported in the year 2020, across the globe.
  • Based on the tested parameters, the DNA is expected to be the fastest-growing segment owing to the growing applications of DNA in genetic screening, pharmacogenomics, and drug metabolism. Moreover, the rising demand for the DNA diagnostics is expected to drive the segment growth during the forecast period.
  • Based on the end use, the healthcare segment dominated the market, garnering a market share of around 52% in 2020. The increased demand for the biotechnology reagents in the various research organizations for clinical diagnostics and clinical trials is spurring the growth of this segment

Ask here for customization study@ https://www.precedenceresearch.com/customization/1378

OBJECTIVES OF THE STUDY

  • To analyze and forecast the Biotechnology Reagents and Kits market, in terms of value and volume
  • To provide information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To define, segment, and project the size of the global Biotechnology Reagents and Kits market on the product type, end-use and other segments
  • To project the size of the market, with respect to five main regions, namely, North America, Europe, Asia Pacific (APAC), the Middle East & Africa, and South America, with their key countries
  • To strategically analyze micromarkets with respect to individual growth trends, growth prospects, and their contribution to the total market
  • To analyze opportunities in the market for stakeholders and provide a competitive landscape of the market leaders
  • To strategically profile key players and comprehensively analyze their core competencies
  • To track and analyze research & development (R&D) and competitive developments such as joint ventures, mergers & acquisitions, and new product developments in the Biotechnology Reagents and Kits market

Research Methodology

  • Market estimate for 2021
  • Average selling price (ASP) per region for specific product type
  • Filtrations and assortment of gathered data, to estimate the base year (2021) market size for the country
  • Gathering data from company websites, annual reports, white papers, financial reports, broker reports, investor presentations, and SEC filings
  • National government documents, statistical databases
  • News articles, press releases, and webcasts specific to companies operating in the market
  • Country wise analysis through internal and external proprietary databases, and relevant patent and regulatory databases
  • Determination of market penetration by country

Major Players Covered in this Report

The updated market research report on Biotechnology Reagents and Kits market allows the buyers and manufacturers to stay updated with the current market trends, ongoing happenings, and a clear picture on the market scenario. List of key players included in the research report will help the market vendors to know their market position and plan more operational strategies to gain topmost position among other players. The report offers crucial company information on each market player, such as company profile, financial information, and recently adopted growth strategies. This will help other existing players and the new entrants to plan strategies and establish their presence in the market.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers
The major players operating in the biotechnology reagents & kits market are Abbott Laboratories, Agilent Technologies, Danaher Corp., Becton Dickinson & Company, Bio-Rad Laboratories, GE Healthcare, Siemens Healthcare, Merck KGaA, Thermo Fisher Scientific Inc., Waters Corporation.

Segments Covered in the Report

By Technology

  • PCR
  • Cell Culture
  • LAMP
  • Chromatography
  • Sequencing
  • Flow Cytometry
  • Electrophoresis
  • Others

By Kits Type

  • Amplifications Kits
  • Isolation Kits
  • Purification Kits
  • Detection Kits
  • Others

By Micro-Organisms

  • Virus
  • Bacteria
  • Fungi
  • Parasites

By Tested Parameters

  • RNA
  • DNA
  • Enzymes
  • Proteins
  • Others

By End User

  • Healthcare
  • Food & Agriculture
  • Industrial Processing
  • Natural Resource & Environment
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biotechnology Reagents & Kits Market 

5.1. COVID-19 Landscape: Biotechnology Reagents & Kits Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biotechnology Reagents & Kits Market, By Kits Type

8.1. Biotechnology Reagents & Kits Market, by Kits Type, 2021-2030

8.1.1. Amplifications Kits

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Isolation Kits

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Purification Kits

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Detection Kits

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Biotechnology Reagents & Kits Market, By Micro-Organisms Type

9.1. Biotechnology Reagents & Kits Market, by Micro-Organisms Type, 2021-2030

9.1.1. Virus

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Bacteria

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Fungi

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Parasites

9.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Biotechnology Reagents & Kits Market, By Technology Type 

10.1. Biotechnology Reagents & Kits Market, by Technology Type, 2021-2030

10.1.1. PCR

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Cell Culture

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. LAMP

10.1.3.1. Market Revenue and Forecast (2019-2030)

10.1.4. Chromatography

10.1.4.1. Market Revenue and Forecast (2019-2030)

10.1.5. Sequencing

10.1.5.1. Market Revenue and Forecast (2019-2030)

10.1.6. Flow Cytometry

10.1.6.1. Market Revenue and Forecast (2019-2030)

10.1.7. Electrophoresis

10.1.7.1. Market Revenue and Forecast (2019-2030)

10.1.8. Others

10.1.8.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Biotechnology Reagents & Kits Market, By Tested Parameters Type

11.1. Biotechnology Reagents & Kits Market, by Tested Parameters Type, 2021-2030

11.1.1. RNA

11.1.1.1. Market Revenue and Forecast (2019-2030)

11.1.2. DNA

11.1.2.1. Market Revenue and Forecast (2019-2030)

11.1.3. Enzymes

11.1.3.1. Market Revenue and Forecast (2019-2030)

11.1.4. Proteins

11.1.4.1. Market Revenue and Forecast (2019-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 12. Global Biotechnology Reagents & Kits Market, By End User Type

12.1. Biotechnology Reagents & Kits Market, by End User, 2021-2030

12.1.1. Healthcare

12.1.1.1. Market Revenue and Forecast (2019-2030)

12.1.2. Food & Agriculture

12.1.2.1. Market Revenue and Forecast (2019-2030)

12.1.3. Industrial Processing

12.1.3.1. Market Revenue and Forecast (2019-2030)

12.1.4. Natural Resource & Environment

12.1.4.1. Market Revenue and Forecast (2019-2030)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 13. Global Biotechnology Reagents & Kits  Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Kits (2019-2030)

13.1.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.1.3. Market Revenue and Forecast, by Technology (2019-2030)

13.1.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.1.5. Market Revenue and Forecast, by End User (2019-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Kits (2019-2030)

13.1.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.1.6.3. Market Revenue and Forecast, by Technology (2019-2030)

13.1.6.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.1.7. Market Revenue and Forecast, by End User (2019-2030)

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Kits (2019-2030)

13.1.8.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.1.8.3. Market Revenue and Forecast, by Technology (2019-2030)

13.1.8.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.1.8.5. Market Revenue and Forecast, by End User (2019-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Kits (2019-2030)

13.2.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.2.3. Market Revenue and Forecast, by Technology (2019-2030)

13.2.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.2.5. Market Revenue and Forecast, by End User (2019-2030)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Kits (2019-2030)

13.2.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.2.6.3. Market Revenue and Forecast, by Technology (2019-2030)

13.2.7. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.2.8. Market Revenue and Forecast, by End User (2019-2030)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Kits (2019-2030)

13.2.9.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.2.9.3. Market Revenue and Forecast, by Technology (2019-2030)

13.2.10. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.2.11. Market Revenue and Forecast, by End User (2019-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Kits (2019-2030)

13.2.12.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.2.12.3. Market Revenue and Forecast, by Technology (2019-2030)

13.2.12.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.2.13. Market Revenue and Forecast, by End User (2019-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Kits (2019-2030)

13.2.14.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.2.14.3. Market Revenue and Forecast, by Technology (2019-2030)

13.2.14.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.2.15. Market Revenue and Forecast, by End User (2019-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Kits (2019-2030)

13.3.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.3.3. Market Revenue and Forecast, by Technology (2019-2030)

13.3.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.3.5. Market Revenue and Forecast, by End User (2019-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Kits (2019-2030)

13.3.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.3.6.3. Market Revenue and Forecast, by Technology (2019-2030)

13.3.6.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.3.7. Market Revenue and Forecast, by End User (2019-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Kits (2019-2030)

13.3.8.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.3.8.3. Market Revenue and Forecast, by Technology (2019-2030)

13.3.8.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.3.9. Market Revenue and Forecast, by End User (2019-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Kits (2019-2030)

13.3.10.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.3.10.3. Market Revenue and Forecast, by Technology (2019-2030)

13.3.10.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2019-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Kits (2019-2030)

13.3.11.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.3.11.3. Market Revenue and Forecast, by Technology (2019-2030)

13.3.11.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2019-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Kits (2019-2030)

13.4.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.4.3. Market Revenue and Forecast, by Technology (2019-2030)

13.4.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.4.5. Market Revenue and Forecast, by End User (2019-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Kits (2019-2030)

13.4.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.4.6.3. Market Revenue and Forecast, by Technology (2019-2030)

13.4.6.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.4.7. Market Revenue and Forecast, by End User (2019-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Kits (2019-2030)

13.4.8.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.4.8.3. Market Revenue and Forecast, by Technology (2019-2030)

13.4.8.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.4.9. Market Revenue and Forecast, by End User (2019-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Kits (2019-2030)

13.4.10.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.4.10.3. Market Revenue and Forecast, by Technology (2019-2030)

13.4.10.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2019-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Kits (2019-2030)

13.4.11.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.4.11.3. Market Revenue and Forecast, by Technology (2019-2030)

13.4.11.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2019-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Kits (2019-2030)

13.5.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.5.3. Market Revenue and Forecast, by Technology (2019-2030)

13.5.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.5.5. Market Revenue and Forecast, by End User (2019-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Kits (2019-2030)

13.5.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.5.6.3. Market Revenue and Forecast, by Technology (2019-2030)

13.5.6.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.5.7. Market Revenue and Forecast, by End User (2019-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Kits (2019-2030)

13.5.8.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.5.8.3. Market Revenue and Forecast, by Technology (2019-2030)

13.5.8.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2019-2030)

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Agilent Technologies

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Danaher Corp.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Becton Dickinson & Company

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Bio-Rad Laboratories

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. GE Healthcare

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Siemens Healthcare

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Merck KGaA

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Thermo Fisher Scientific Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Waters Corporation

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Buy this Research Report study@ https://www.precedenceresearch.com/checkout/1378

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

For Latest Update Follow Us:

https://www.linkedin.com/company/precedence-research/

https://www.facebook.com/precedenceresearch/

https://twitter.com/Precedence_R

Steve Robber

My name is Steve Robber, I’m the Owner of Market Stats News. Steve has served in many positions at various organizations for the past seven years. Currently he is an Author at Finance.Yahoo. Contact us for a free news publication, we look forward to speaking with you!

Related Articles

Back to top button